|
全国免费电话:400-668-6834 -- 仅限中国地区 -- |
在线订购:QQ: 4006686834 电话订购:021-68591985 邮件订购:info@selleck.cn 我们也提供销售人员上门服务 |
技术支持电话:400-168-6834 我们将于一个工作日与您联系 |
目录号:A2103
克隆号:9H10
Anti-mouse CTLA-4 (CD152) (克隆号:9H10)可与小鼠CTLA-4(CD152)反应。Anti-mouse CTLA-4 (CD152)抗体通过阻断CTLA-4与B7共受体的结合,促进CD28结合,从而促进T细胞共刺激。
| 分子量 | 150 kDa |
|---|---|
| 克隆号 | 9H10 |
| 免疫原 | Mouse CTLA-4-human IgG1 fusion protein |
| 配制 | PBS buffer, pH 7.0 |
| 推荐同型对照 | Syrian hamster IgG |
| 应用 | in vivo/vitro CTLA-4 neutralization, FCM,WB |
| 来源 | CHO |
| 储存条件 (自收到货起) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| 纯化 | Protein G |
| 除菌 | 0.2 μM filtered |
| HBx hijacks the miR-19a-3p/BAMBI/TGF-β1 axis to impair the anti-tumour activity of CD4+ T cells in diffuse large B-cell lymphoma [ Clinical and Translational Medicine, 2026, e70578] | PubMed: 41492119.0 |
| N-terminal acetylation of transcription factor LIP induces immune therapy resistance via suppression of PD-L1 expression in non-small cell lung cancer [ J Immunother Cancer, 2024, 12(11)e009905] | PubMed: 39615895 |
| N-terminal acetylation of transcription factor LIP induces immune therapy resistance via suppression of PD-L1 expression in non-small cell lung cancer [ Journal for ImmunoTherapy of Cancer, 2024, e009905] | PubMed: 39615895.0 |
禁止用于人体及治疗!